SEATTLE, Nov. 25, 2015 /PRNewswire/ -- ActX partners with NewCrop and announces the launch of its real-time genomic decision support service for NewCrop customers. The integration of ActX into NewCrop's prescribing system means providers using one of NewCrop's 100+ partner Electronic Health Record (EHR) systems can see genetically based alerts about medication efficacy, dosing, and adverse reactions during prescribing.
ActX's innovative solution makes genomics practical for NewCrop providers at the point of care, built into providers' normal workflow. Based on affordable patient DNA testing, ActX checks each prescription for possible adverse reactions as well as efficacy issues using the patient's genetic code. In addition, the ActX application alerts the physician about any serious, actionable medical risks.
"We're extremely excited to be making the dream of precision medicine a reality for NewCrop prescribers," says Andrew Ury M.D., ActX CEO. "With alerts about drug-genomic interactions right at the point of care, we can begin to integrate genomics into physicians' everyday patient care."
"We're pleased to be working with ActX to provide genomic decision support to our doctors and their patients," says Lawrence Susnow M.D., President of NewCrop. "This new information is now integrated with the prescribing sequence. Drugs with potential genomic concerns are noted. Once a patient has completed their analysis, alerts specific to their genome will appear. NewCrop and ActX now allow physicians to personalize their patient's treatment, based on genomics."
The ActX Service is available today for NewCrop and its associated EHR partners, and delivers the actionable, evidence based information physicians need in a way they can trust. With ActX, physicians can use their EHR to provide better informed care for their patients.
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient's genetic information to guide therapy. Integrated into a physician's normal software tools (the electronic medical record) and workflow, ActX analyzes the patient's genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks. For more information about ActX and taking the next step towards precision medicine, visit us at www.actx.com, or contact us at email@example.com.
888 | 998 2289
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/actx-partners-with-newcrop-300184444.html
SOURCE ActX, Inc.